129 related articles for article (PubMed ID: 27760829)
1. Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis.
Martin-Vicente A; Capilla J; Guarro J
Med Mycol; 2017 Jun; 55(4):457-460. PubMed ID: 27760829
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
[TBL] [Abstract][Full Text] [Related]
3. Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis.
Siopi M; Siafakas N; Vourli S; Mouton JW; Zerva L; Meletiadis J
J Antimicrob Chemother; 2016 Nov; 71(11):3135-3147. PubMed ID: 27494912
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Synergy of Amphotericin B plus Posaconazole in Murine Aspergillosis.
Martin-Vicente A; Capilla J; Guarro J
Antimicrob Agents Chemother; 2016 Jan; 60(1):296-300. PubMed ID: 26503653
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus.
Bedin Denardi L; Pantella Kunz de Jesus F; Keller JT; Weiblen C; de Azevedo MI; Oliveira V; Morais Santurio J; Hartz Alves S
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):40-43. PubMed ID: 29126660
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.
Lewis RE; Liao G; Hou J; Prince RA; Kontoyiannis DP
J Antimicrob Chemother; 2011 Jun; 66(6):1324-31. PubMed ID: 21486855
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Calvo E; Pastor FJ; Salas V; Mayayo E; Guarro J
Mycopathologia; 2012 Apr; 173(4):251-7. PubMed ID: 22139415
[TBL] [Abstract][Full Text] [Related]
8. Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
Galiger C; Brock M; Jouvion G; Savers A; Parlato M; Ibrahim-Granet O
Antimicrob Agents Chemother; 2013 Jul; 57(7):3046-59. PubMed ID: 23587947
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
Krishnan-Natesan S; Wu W; Chandrasekar PH
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models.
Kai H; Yamashita M; Nakamura I; Yoshikawa K; Nitta K; Watanabe M; Inamura N; Fujie A
J Antibiot (Tokyo); 2013 Aug; 66(8):479-84. PubMed ID: 23756682
[TBL] [Abstract][Full Text] [Related]
11. Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.
Spreghini E; Orlando F; Santinelli A; Pisa E; Loretelli C; Manso E; Milici ME; Scalise G; Barchiesi F
Antimicrob Agents Chemother; 2009 Sep; 53(9):4035-9. PubMed ID: 19596890
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.
Seyedmousavi S; Brüggemann RJ; Melchers WJ; Verweij PE; Mouton JW
Antimicrob Agents Chemother; 2013 Jan; 57(1):303-8. PubMed ID: 23114773
[TBL] [Abstract][Full Text] [Related]
13. Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
Cacciapuoti A; Halpern J; Mendrick C; Norris C; Patel R; Loebenberg D
Antimicrob Agents Chemother; 2006 Jul; 50(7):2587-90. PubMed ID: 16801452
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Li SX; Song YJ; Jiang L; Zhao YJ; Guo H; Li DM; Zhu KJ; Zhang H
Microb Drug Resist; 2017 Sep; 23(6):674-681. PubMed ID: 28080217
[TBL] [Abstract][Full Text] [Related]
15. Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates.
Lepak AJ; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5438-47. PubMed ID: 23959322
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Clemons KV; Parmar R; Martinez M; Stevens DA
J Antimicrob Chemother; 2006 Aug; 58(2):466-9. PubMed ID: 16760192
[TBL] [Abstract][Full Text] [Related]
17. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
Sionov E; Mendlovic S; Segal E
J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
[TBL] [Abstract][Full Text] [Related]
18. Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
Jeans AR; Howard SJ; Al-Nakeeb Z; Goodwin J; Gregson L; Warn PA; Hope WW
Antimicrob Agents Chemother; 2012 Oct; 56(10):5180-5. PubMed ID: 22825124
[TBL] [Abstract][Full Text] [Related]
19. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
[TBL] [Abstract][Full Text] [Related]
20. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
